Cleveland Clinic team draws a link between COVID-19 protection and the sleep aid melatonin – FierceBiotech

The idea of repurposingexisting medicines as a fast approach to containing COVID-19 is still popular, even as vaccines and antibodies designed to combat the disease are starting to gain steam. Scientists at the Cleveland Clinic are among those examining existing compounds as possible treatments for the coronavirus, and now they're suggesting that the popular over-the-counter sleep aid melatonin may be a possible option in treating the disease. The researchers used an artificial intelligence tool to analyze data from 26,779 individuals in the Cleveland Clinics COVID-19 registry, of whom 8,274 tested positive for SARS-CoV-2, the novel coronavirus that causes COVID-19

Read more
ARC success for University of Sydney researchers – News – The University of Sydney

Investigator/sProjectAmount awardedProfessor Adrian Vickers; Professor Yixu Lu; Associate Professor Rebecca Suter; Dr Sophie Loy-Wilson; Dr Cat Moir; Dr Sonia Wilson; Dr Josh Stenberg; Associate Professor Giorgia AlOpening Australia's Multilingual Archive$949,564Professor Brent Kaiser;Professor Dabing Zhang; Dr Chandrika Deshpande;Dr Kanwarpal Dhugga; Dr Nijat IminHow do plant roots align nitrogen uptake to soil opportunities?$621,878Professor Peter Lay; Professor Georges GrauMetal Virulence and Therapeutic Factors in Pathogen Bioinorganic Chemistry$600,000Professor Alison Betts; Professor Lloyd Weeks;Dr Kunlong Chen; Professor Jianjun MeiBronzes of Xinjiang: technology, society and power on the road to China$596,789Professor Justin Harris;Professor Mark BoutonExtinction of conditioned responding: Learning from the evidence of absence$590,356Associate Professor Anthony Cesare; Professor Simon BoultonUnderstanding telomere privilege in pluripotent stem cells.$555,892Professor David James; Associate Professor Elizabeth New; Dr James Burchfield; Dr Jacqueline Stoeckli; Dr Guang Yang;Dr Guang Yang; Professor Scott SummersUnravelling a canonical mitochondrial stress response pathway$545,000Professor Hak-Kim Chan; Professor Mark Banaszak Holl;Dr Sandra MoralesUnderstanding bacteriophage deactivation and stabilisation in formulations$540,762Professor Fariba Dehghani; Dr Sina Naficy; Dr Farshad Oveissi; Professor Anthony Weiss;Professor Alessandro PaccagnellaMiniaturised biosensors with high selectivity$539,765Dr Camilla Whittington; Dr Catherine Grueber;Professor Scott EdwardsWatching evolution in action using transitional forms of lizard pregnancy$514,943Professor Min ChenMolecular adaptation of photosynthesis powered by long-wavelength light$509,000Professor Louise Sharpe; Associate Professor Ben Colagiuri; Dr Jemma Todd; Associate Professor Hamish MacDougall;Assistant Professor Dimitri Van Ryckeghem; Professor Dr Geert CrombezTo focus on pain or not to focus: WHEN is the question$506,237Professor David Alais; Professor Frans Verstraten;Professor David BurrMultisensory perception in active observers$503,000Professor Nalini JoshiDynamics on space-filling shapes$501,777Associate Professor Buhui Qiu; Associate Professor Eliza Wu;Professor Iftekhar Hasan; Professor Yan YuReshaping the landscape of bank monitoring and risk disclosures$496,288Associate Professor Damian Birney; Professor Sally Cripps; Professor Dr Jens Beckmann;Associate Professor Rui NouchiA paradigm shift in understanding cognitive flexibility$493,123Dr Chang Xu;Dr Surya Nepal; Dr Siqi MaDeepHoney: Automatic Honey Data Generation for Active Cyber Defence$480,000Professor Karl Maton; Associate Professor Sarah Howard; Associate Professor Philip Roberts; Professor Christian Ritz; Dr Jie Yang; Dr Yaegan DoranBuilding on rural knowledges to unlock the potential of rural students$467,340Professor Neal Peres Da Costa; Dr Amanda Harris; Professor Jaky Troy; Dr Toby Martin;Dr Matthew StephensHearing the music of early New South Wales, 1788-1860$457,669Associate Professor Laurence Macia; Professor Georges Grau; Professor Nicholas King; Professor Ralph NananThe maternal gut microbiota drives foetal thymic T cell development$451,750Dr Anne Mai-Prochnow; Professor Dee Carter;Associate Professor Scott RiceBiofilm responses to cold atmospheric plasma$451,480Professor Alan Fekete; Professor Willy Zwaenepoel; Dr Shuaiwen Song; Associate Professor Bernhard ScholzAdaptive Key-value Store for Future Extreme Heterogeneous Systems$450,000Associate Professor Zhiyong Wang; Professor Mohammed Bennamoun; Associate Professor Markus Hagenbuchner; Professor Ah Chung Tsoi; Professor Simon LewisFine-grained Human Action Recognition with Deep Graph Neural Networks$444,416Dr Kevin Coulembier;Dr Pavel EtingofNew constructions and techniques for tensor categories$422,887Associate Professor Zongwen LiuA Self-Repairing Entropy-Stabilized Oxide as a Protective Coating$420,000Professor Branka Vucetic; Professor Yonghui Li; Dr Peng Cheng; Dr Wibowo HardjawanaWireless Cellular Connectivity for Large Scale Critical Applications$420,000Professor Dean RicklesThe Development of Quantum Gravity (1957-1988): The Great Divide$412,000Professor Kim Rasmussen; Associate Professor Hao Zhang; Professor Anna Paradowska;Dr Ondrej Muransky; Professor Leroy GardnerReliability and design of 3D printed metal structures$408,164Dr Liwei Li; Professor Xiaoke YiMicrowave photonics and photonic integration for advanced sensing$405,000Professor Timothy Bedding;Assistant Professor Daniel HuberUnveiling missing physics: looking inside stars with NASA's TESS Mission$390,000Associate Professor John Ormerod; Dr Garth Tarr; Professor Samuel MullerFast flexible feature selection for high dimensional challenging data$390,000Associate Professor Carolyn MacCann; Dr Rebecca Pinkus; Associate Professor Helena Nguyen;Associate Professor Anya Johnson;Dr Karen Niven; Professor James GrossWhen, why, and how well do we regulate other people's emotions?$389,000Professor Olivier Piguet; Dr Ramon Landin-RomeroHuman hippocampus subregions organisation and associative memory processes$382,865Professor Glenda Wardle; Professor Chris Dickman; Dr Aaron Greenville; Dr Ayesha Tulloch; Dr Thomas Newsome;Associate Professor Michael DietzeEcological forecasts of species response to fire, drought and heatwaves$371,000Professor Philip Gale;Associate Professor Vtor Flix; Dr Jonathan SteedCreating custom microenvironments for anion complexation in water$370,000Professor Bart Anderson;Professor Karl Gegenfurtner; Professor Dr Felix WichmannEmergent cues underlying the perception of shape, colour, and material$365,000Dr Laurence Troy; Professor Bill RandolphThe precarious city: the suburban settlement in an age of uncertainty$348,000Dr Alexander FishAdditive combinatorics of infinite sets via ergodic theoretic approach$340,000Associate Professor Nicolas de Roos; Associate Professor David Byrne; Associate Professor Matthew LewisPrice Transparency, Search, and Collusion in Markets$311,801Professor Holger Dullin; Dr Robert Marangell;Professor Yuri LatushkinSpectral Theory of Hamiltonian Dynamical Systems$310,000Professor Gregory Hancock; Dr Cao Hung Pham;Professor Colin RogersNew Systems for High Rise Steel Structures in Rising Factory Construction$295,010Professor Benjamin Oldroyd; Professor Madeleine Beekman;Associate Professor Amro ZayedThe Cape honey bee and the origins of virgin birth$288,760Associate Professor Francesco Borghesi; Professor Yixu Lu;Dr Daniel Canaris; Professor Thierry MeynardTransforming the East: Jesuit Translations of the Confucian Classics$229,950Professor Sujatha FernandesMigrant Worlds: Labouring Lives and Worker Consciousness in Global Cities$228,435Associate Professor Yane Svetiev; Associate Professor Andrew EdgarPeer Review of Financial Regulatory Agencies$212,000Associate Professor Nicole Graham; Associate Professor Robyn BartelTenants of the soil: adapting agricultural land ownership in Australia$171,488Associate Professor Wendy Davis; Assistant Professor Dorukalp Durmus;Dr Wenye HuReducing the energy consumed by lighting with gaze-dependent illumination$111,689

Read more
FUJIFILM Cellular Dynamics and Lonza Agree to Expand the Availability and Use of Induced Pluripotent Stem Cell Technology – BioSpace

About Lonza At Lonza, we combine technological innovation with world class manufacturing and process excellence. Together, these enable our customers to deliver their discoveries in the healthcare, preservation, and protection sectors. We are a preferred global partner to the pharmaceutical, biotech and specialty ingredients markets.

Read more
Rheumatoid Arthritis Stem Cell Therapy Market to Ride on Increased Prevalence of Rheumatoid Arthritis – TMR Research Blog

Rheumatoid arthritis refers to an inflammatory disease of the supportive tissues of the body and the condition generally affects fingers and toes of human beings. This inflammation is caused by an abnormal response of the body to the normal functioning tissues. This leads to acute pain and malformed joints.

Read more
Lineage Cell Therapeutics Proudly Supports Patients’ Access to Innovative Cell Therapy Treatments and Research Through Passage of Proposition 14 -…

At Lineage, the patients and their families inspire us to advance cell therapy products and this recent approval of Proposition 14 ensures that access to cutting edge cell-based therapies can continue from companies like ours, stated Brian M. Culley, Lineage CEO. Cell therapy has the ability to make a profound impact on millions of lives and the passage of Proposition 14 reflects Californias serious commitment to supporting innovative local companies through the expensive and time-consuming process required to discover and test new cell-based therapies and will drive further innovation in stem cell development and research.

Read more
Global Cancer Stem Cells (CSCs) Market 2026 Competitive Analysis on the Performance of Key Industry Players Janssen, Qiagen, Advanced Cell…

Latest Published Report on Global Cancer Stem Cells (CSCs) Market with focus on In-Depth Industry Analysis, Regionwise Forecasts, Product Applications, Growth Projections, Competitive Developments and Challenges, Business Investments and Opportunities by 2026. This research report contains an through information on all the main aspects of the global Cancer Stem Cells (CSCs) market. This report contains important data such as facts and figures, market research, market analysis, competitor analysis, risk analysis, demand analysis, regional trends and current market status.

Read more
UB researcher narrows time window for administering specific treatment to infants with Krabbe disease – UB Now: News and views for UB faculty and…

A team of UB researchers has published a paper in Nature Communications that is helping to define the best time to give a specific treatment to infants born with Krabbe disease (KD). This treatment has been found to prolong life for these infants for as long as a few years. The paper was published online in Nature Communication Oct

Read more
Promising Results for Chemotherapy-Free Induction/Consolidation Therapy in Philadelphia-Positive ALL – Cancer Therapy Advisor

Use of BCR1/ABL receptor tyrosine kinase inhibitor (TKI)-based induction therapy followed by consolidation therapy with the bispecific T-cell engager (BiTE), blinatumomab, without addition of chemotherapeutic agents, in the treatment of adults with Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia (ALL), was associated with a high survival rate and very low treatment toxicity, according to results of a phase 2 study published in the New England Journal of Medicine.1 Multiagent intensive chemotherapy has traditionally formed the backbone of initial therapy for patients with newly diagnosed ALL, although previous research has shown that the benefits of this approach decreased with increasing patient age.2 While a long-term cure rate of approximately 90% has been achieved in children with ALL who have undergone aggressive chemotherapy-based induction/consolidation therapy, only 70% of adolescents and young adults aged 40 years or younger with newly diagnosed ALL who received this type of treatment were cured.

Read more